J Cancer Prev 2021; 26(1): 18-24
Published online March 30, 2021
© Korean Society of Cancer Prevention
1Department of Chemical Biology, Ernest Mario School of Pharmacy, 2Toxicology Graduate Program, Rutgers, The State University of New Jersey, Piscataway, NJ, USA, 3Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Endocrine disruptors, such as bisphenol A (BPA), have become more frequently present in the environment as contaminants, especially in industrialized countries. Long-term effects of these environmental contaminants in humans are elusive. With their structural similarity to estrogen, many environmental contaminants including BPA, have been shown to mimic the biological functions of estrogen, potentially contributing to the development of breast cancer. It has been well established that BPA exerts estrogenic activity in animal models and in vitro systems. There is a concern for adverse effects from the exposure to BPA in regard to developmental and reproductive toxicities. However, the mechanisms by which BPA promotes breast cancer development remain unknown. Understanding the role of endocrine disruptors and their key mechanisms of action is important for public health, especially by providing a foundation for a better intervention approach in cancer prevention.
Keywords: Breast cancer, Cancer stem cells, Endocrine disruptors, Estrogen receptor
Young Eun Choi, Chang Hoon Cho, Hye Ok Kim, Yong Hwa Jo, Jun-Kyu Song, Hyung Hwan Baik, Wonchae Choe, Insug Kang and Kyung-Sik YoonCancer prevention research 2009; 14(1): 20-27
Ji-Young Park, Soma Saeidi, Eun-Hee Kim, Do-Hee Kim, Hye-Kyung Na, Joo-Seob Keum, Young-Joon SurhJ Cancer Prev 2021; 26(1): 54-63 https://doi.org/10.15430/JCP.2021.26.1.54
Jeehye Choi, Jin-Young Suh, Do-Hee Kim, Hye-Kyung Na, Young-Joon SurhJ Cancer Prev 2020; 25(3): 152-163 https://doi.org/10.15430/JCP.2020.25.3.152